Literature DB >> 16673614

Cancer presenting as fatal pulmonary tumour embolism.

D Deeren1, E Verbeken, S Vanderschueren, A Wilmer, H Bobbaers, W Meersseman.   

Abstract

Rapidly fatal pulmonary tumour embolism is a rare complication of malignancy, and often presents as progressive dyspnea without obvious cause. We describe two cases presenting with a dramatic clinical picture of lactic acidosis and cardiopulmonary arrest soon after admission on ICU. The first patient was a 29-year old woman with a breast cancer seeming in remission who was admitted with rapidly increasing dyspnea since two weeks. The second patient was a 46-year old woman with HIV and no history of malignancy, who developed dyspnea and lactic acidosis over the course of a few days while she was investigated for an occipital brain lesion. Both patients died soon after admission and massive tumour emboli were found on autopsy. Breast cancer was the origin of the emboli in both cases. Symptoms were out of proportion to the initial physical cardiopulmonary findings and radiographic features. Clinical signs of pulmonary tumour embolism are non-specific and subacute. Prognosis is poor and definite diagnosis is usually made post-mortem. Solid malignancies such as breast cancer account for most of the cases. Pulmonary tumour embolism should be considered in critically ill patients with unexplained hypoxemia and lactic acidosis, mild or no radiological abnormalities and fast clinical deterioration. It may occur in young patients and in patients without history of malignancy.

Entities:  

Mesh:

Year:  2006        PMID: 16673614     DOI: 10.1179/acb.2006.006

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

1.  Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.

Authors:  Gloria Bonuccelli; Aristotelis Tsirigos; Diana Whitaker-Menezes; Stephanos Pavlides; Richard G Pestell; Barbara Chiavarina; Philippe G Frank; Neal Flomenberg; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-21       Impact factor: 4.534

2.  Clinical analysis of tumor and non-tumor patients complicated with pulmonary embolism.

Authors:  Hong Wang; Yuan Huang; Chun-Wei Xu; Li Lin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 3.  Lactate, a Neglected Factor for Diabetes and Cancer Interaction.

Authors:  Yong Wu; Yunzhou Dong; Mohammad Atefi; Yanjun Liu; Yahya Elshimali; Jaydutt V Vadgama
Journal:  Mediators Inflamm       Date:  2016-12-18       Impact factor: 4.711

4.  Pulmonary tumor embolism: A retrospective study over a 30-year period.

Authors:  Xin He; Douglas C Anthony; Zulmira Catoni; Weibiao Cao
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.